US Stock MarketDetailed Quotes

NRSN NeuroSense Therapeutics

Watchlist
  • 0.950
  • -0.040-4.04%
Trading Nov 21 15:01 ET
18.82MMarket Cap-1461P/E (TTM)

NeuroSense Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NeuroSense Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

NeuroSense Therapeutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 31 17:01 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 30 16:58 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 16 16:09 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 24 09:25 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 12, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data